Company Search:
Advanced Search
Sponsored Links
Genovate Biotechnology Co., Limited Company Snapshot
Genovate Biotechnology Co., Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genovate Biotechnology Co., Limited with three other companies in this sector in TAIWAN : General Biological Corporation (2020 sales of 475.87 million Taiwanese Dollars [US$17.20 million] ), UBI Pharma Inc (477.56 million Taiwanese Dollars [US$17.26 million] of which 75% was Contract Medicine Manufacturing), and TSH Biopharm Corp Limited (447.86 million Taiwanese Dollars [US$16.19 million] of which 95% was Medicine).

Sales Analysis. During the year ended December of 2020, sales at Genovate Biotechnology Co., Limited were 472.72 million Taiwanese Dollars (US$17.09 million). This is a very small increase of 1.5% versus 2019, when the company's sales were 465.76 million Taiwanese Dollars . This was the third consecutive year of growth at Genovate Biotechnology Co., Limited. The sales level in 2020 was fairly close to the level five years ago: in 2015, Genovate Biotechnology Co., Limited had sales of 477.60 million Taiwanese Dollars . Sales of Other saw an increase that was more than double the company's growth rate: sales were up 1,470.1% in 2020, from 278,000.00 Taiwanese Dollars to 4.37 million Taiwanese Dollars . Not all segments of Genovate Biotechnology Co., Limited experienced an increase in sales in 2020: sales of Technical Service fell 39.1% to 2.38 million Taiwanese Dollars . (However, this segment's sales were only a very small portion of the company's overall sales). Genovate Biotechnology Co., Limited also experienced decreases in sales in Agency (down 0.8% to 22.75 million Taiwanese Dollars ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genovate Biotechnology Co., Limited
  Stock Performance Chart for Genovate Biotechnology Co., Limited
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 25.55
(Figures in Taiwanese Dollars )
1 Week 2.4%   13 Weeks -2.9%  
4 Weeks -7.8%   52 Weeks -16.5%  
Genovate Biotechnology Co., Limited Key Data:
  Ticker: 4130 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 472,723,000
(Year Ending Jan 2021).
Employees: 178
  Currency: Taiwanese Dollars Market Cap: 2,702,193,550
  Fiscal Yr Ends: December Shares Outstanding: 105,761,000
  Share Type: Gu Closely Held Shares: 44,825,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.